In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cef ixime, in comparison with other drugs, against Haemophilus influenzae, haemophilus parainfluenzae, moraxella catarrhalis and streptococcus pneumoniae